Prestige Consumer Healthcare Inc

NYSE:PBH

United States / Healthcare / Pharmaceuticals

Overview

News

5Y Historical Financials

Stock Price

85.73 USD


Key Metrics	Latest
Total Revenue	1.118 B
Adjusted EBITDA	361.3 M
EBITDA Margin	32.3%
Net Profit Margin	19.1%
Total Assets	3.329 B
Total Debt	1.027 B

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Mar-20	Mar-21	Mar-22	Mar-23	Mar-24	12 Months	Dec-23	Dec-24

Revenue	963.01	943.37	1,086.81	1,127.73	1,125.36	1,118.24	848.37	841.24
% Growth		(0.02)	0.15	0.04	(0.00)			(0.01)

Adjusted EBITDA	320.15	330.00	368.17	380.43	373.10	361.26	283.11	271.27
% Margin	0.33	0.35	0.34	0.34	0.33	0.32	0.33	0.32

Adjusted EBIT	291.16	299.84	336.08	347.80	342.43	330.50	260.28	248.35
% Margin	0.30	0.32	0.31	0.31	0.30	0.30	0.31	0.30

Adjusted Net Income	143.88	175.61	211.51	191.65	209.34	213.94	159.88	164.48
% Margin	0.15	0.19	0.19	0.17	0.19	0.19	0.19	0.20

Adjusted Basic EPS	2.84	3.50	4.21	3.84	4.21	4.30	3.21	3.31

Supporting Calculations

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Original
USD	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Mar-20	Mar-21	Mar-22	Mar-23	Mar-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	963	943	1,087	1,128	1,125	1,118	848	841
% Growth	NA	-2.0%	15.2%	3.8%	-0.2%			-0.8%

Cost of Revenue	(407)	(390)	(459)	(495)	(493)	(493)	(370)	(370)
Gross Profit	556	554	628	633	633	625	479	471
% Revenue	57.8%	58.7%	57.8%	56.1%	56.2%	55.9%	56.4%	56.0%

Research and Development	0	0	0	0	0	0	0	0
Selling and Marketing	(147)	(141)	(157)	(145)	(153)	(156)	(116)	(119)
General and Admin	(89)	(83)	(102)	(107)	(106)	(108)	(80)	(81)
Other Inc / (Exp)	(33)	(44)	(41)	(405)	(30)	(32)	(23)	(24)
Total Operating Exp	(269)	(267)	(301)	(658)	(289)	(295)	(218)	(224)

Operating Income	287	286	327	(25)	343	330	261	247
% Revenue	29.8%	30.4%	30.1%	-2.2%	30.5%	29.5%	30.7%	29.4%

Interest Expense	(96)	(82)	(64)	(69)	(67)	(52)	(52)	(37)
Pre-tax Income	191	204	262	(94)	276	278	209	210
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0
Provision for Taxes	(49)	(39)	(57)	12	(67)	(64)	(49)	(46)
Net Income to Company	142	165	205	(82)	209	214	160	164
% Margin	14.8%	17.5%	18.9%	-7.3%	18.6%	19.1%	18.8%	19.6%

Minority Interest in Earnings	0	0	0	0	0	0	0	0
Net Income to Stockholders	142	165	205	(82)	209	214	160	164

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0

Net Income to Common	142	165	205	(82)	209	214	160	164
% Margin	14.8%	17.5%	18.9%	-7.3%	18.6%	19.1%	18.8%	19.6%

As Reported
Basic EPS (Continuing Ops)	2.81	3.28	4.09	(1.65)	4.21	4.30	3.21	3.31
Diluted EPS (Continuing Ops)	2.78	3.25	4.04	(1.65)	4.17	4.26	3.19	3.28

WA Basic Shares Out.	50.72	50.21	50.26	49.89	49.76	49.74	49.73	49.71
WA Diluted Shares Out.	51.14	50.61	50.84	49.89	50.18	50.13	50.13	50.09

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	191	204	262	(94)	276	278	209	210
Addback: Net Interest Expense	96	82	64	69	67	52	52	37
Addback: Other Non Operating Expenses, Total	2	(1)	1	2	(1)	1	(0)	1
Addback: Depreciation & Amortization	29	30	32	33	31	31	23	23
Addback: Restructuring Charges	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	0	0	5	0	0	0	0	0
Addback: Goodwill Impairment	0	1	0	49	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	0	0	0
Addback: Asset Writedown	0	1	1	321	0	0	0	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	2	12	2	0	0	0	0	0
Adjusted EBITDA	320	330	368	380	373	361	283	271
% Margin	33.2%	35.0%	33.9%	33.7%	33.2%	32.3%	33.4%	32.2%

Adjusted EBIT	291	300	336	348	342	331	260	248
% Margin	30.2%	31.8%	30.9%	30.8%	30.4%	29.6%	30.7%	29.5%

Adjusted Net Income Reconciliation
Net Income to Company	142	165	205	(82)	209	214	160	164
Addback: Unusual Items	2	15	8	370	0	0	0	0
Less: Tax Benefit of Unusual Items (26%)	(1)	(4)	(2)	(96)	0	0	0	0
Adjusted Net Income	144	176	212	192	209	214	160	164
% Margin	14.9%	18.6%	19.5%	17.0%	18.6%	19.1%	18.8%	19.6%

Loading Error

Prestige Consumer Healthcare Inc

NYSE:PBH

United States / Healthcare / Pharmaceuticals

5Y Historical Financials